Opinicus Capital’s Eli Lilly LLY Stock Holding History

Opinicus Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.47M	Sell	3,862 -137	-3%	-$162K	2.41%	13
2026 Q2	$4.8M	Sell	3,999 -20	-0.5%	-$20.4K	2.57%	11
2026 Q1	$3.7M	Sell	4,019 -12	-0.3%	-$12.2K	2.61%	11
2025 Q4	$4.33M	Sell	4,031 -303	-7%	-$290K	3.02%	8
2025 Q3	$3.31M	Buy	4,334 +738	+21%	+$549K	2.29%	10
2025 Q2	$2.8M	Buy	3,596 +101	+3%	+$78.5K	2.13%	10
2025 Q1	$2.89M	Sell	3,495 -129	-4%	-$107K	2.55%	9
2024 Q4	$2.8M	Sell	3,624 -83	-2%	-$68.7K	2.35%	10
2024 Q3	$3.28M	Buy	3,707 +61	+2%	+$54.8K	2.63%	9
2024 Q2	$3.3M	Buy	3,646 +21	+0.6%	+$16.8K	2.78%	9
2024 Q1	$2.82M	Buy	3,625 +40	+1%	+$28.5K	2.5%	9
2023 Q4	$2.09M	Buy	+3,585	New	+$2.09M	2.13%	11

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

Opinicus Capital's LLY Position: Q3 2026 in Review

Opinicus Capital reduced its Eli Lilly (LLY) stake by 3.4% in Q3 2026, selling an estimated $162K and leaving 3,862 shares worth $4.47M. The position accounts for 2.41% of the portfolio, ranked #13.

Opinicus Capital first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $4.8M in Q2 2026. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Opinicus Capital held 3,862 shares of Eli Lilly worth $4.47M as of Q3 2026.
Opinicus Capital sold 137 Eli Lilly shares in Q3 2026, an estimated $162K.
Eli Lilly made up 2.41% of Opinicus Capital's portfolio in Q3 2026, its #13 holding.
Opinicus Capital first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
Opinicus Capital's Eli Lilly position peaked at $4.8M in Q2 2026.
2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Opinicus Capital's 13F filing for Q3 2026, filed 28 Oct 2026.